Azacitidine (AZA) and donor lymphocyte infusion (DLI) is a viable salvage approach for chimerism-only relapse following allogeneic blood or marrow transplantation (BMT)
Year: 2025
Type: conference-abstract
Source: Blood
Institution: Johns Hopkins University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417015163
Cites:
Cited by:
Related to: